Viral Oncology Laboratories, University of Manchester Institute of Cancer Sciences, Manchester, UK.
J Med Virol. 2014 Apr;86(4):672-7. doi: 10.1002/jmv.23868. Epub 2013 Dec 30.
Although subclinical persistent infections with the human polyomaviruses BKV and JCV are ubiquitous worldwide, these are known to vary in relation to diseases present and geographical location. DNAs from 220 cervical smears and 109 invasive cervical carcinomas obtained from HIV positive and HIV negative Kenyan women of known HPV status were analyzed by nested endpoint PCR for BKV and JCV. BKV-JCV DNA was detected in 5/105 (4.7%) of cervical smears and in 6/37 (16%) of cervical carcinomas from women infected with HIV whereas 9/115 (7.8%) of the cervical smears and 4/72 (5.5%) of the carcinomas were positive in HIV negative women. Nested PCR showed that all 24 samples were positive for JCV and not BKV. JCV was not more prevalent in either HPV positive (P = 0.438) or HPV negative women (P = 0.392). However, 37% of carcinomas and smears which were positive for JCV were also positive for a "high-risk" oncogenic HPV. Comparison of the incidence of JCV in cervical smears and cervical carcinomas showed a ∼3-fold increase in samples from HIV positive women with cervical carcinoma (P = 0.025) whereas no significant difference was found between cervical smears and cervical carcinomas from HIV negative women (P = 0.553). These results suggest that JCV may combine with high-risk HPV infection in women infected with HIV to influence the rate of progression to invasive cervical carcinoma.
尽管人类多瘤病毒 BKV 和 JCV 的亚临床持续性感染在全球范围内普遍存在,但已知这些病毒会因现有疾病和地理位置的不同而有所变化。通过巢式终点 PCR 分析了来自已知 HPV 状态的肯尼亚 HIV 阳性和 HIV 阴性女性的 220 份宫颈涂片和 109 份浸润性宫颈癌的 220 份宫颈涂片和 109 份浸润性宫颈癌的 DNA,以检测 BKV 和 JCV。在感染 HIV 的女性中,5/105(4.7%)的宫颈涂片和 6/37(16%)的宫颈癌中检测到 BKV-JCV DNA,而在 HIV 阴性女性中,9/115(7.8%)的宫颈涂片和 4/72(5.5%)的宫颈癌为阳性。巢式 PCR 显示所有 24 个样本均为 JCV 阳性,而非 BKV 阳性。JCV 在 HPV 阳性(P=0.438)或 HPV 阴性女性(P=0.392)中均不更为普遍。然而,37%的 JCV 阳性的宫颈癌和宫颈涂片也同时为“高危”致癌 HPV 阳性。比较宫颈涂片和宫颈癌中 JCV 的发生率,发现 HIV 阳性宫颈癌女性的样本 JCV 发生率增加了约 3 倍(P=0.025),而 HIV 阴性女性的宫颈涂片和宫颈癌之间则没有显著差异(P=0.553)。这些结果表明,JCV 可能与 HIV 感染女性的高危 HPV 感染相结合,影响向浸润性宫颈癌的进展速度。